bpc-157 human clinical trial safety What no one's telling you about π§ͺ #peptides #orthopedics #ortho bpc-157 human clinical trials evidence
Description
The data suggests that the lipolytic fragment of growth hormone might have the potential to be developed into a safe oral dose for obesity [1]
Many peptides are cleared from the bloodstream shortly after administration resulting in limited exposure to the brain capillaries, reducing their ability to penetrate the BBB
This must be stated clearly in the product data sheet
Over multiple vials, this adds up
